Abstract
Background—Vorapaxar is a novel antagonist of protease-activated receptor-1, the primary receptor for thrombin on human platelets that is also present on vascular endothelium and smooth muscle. Pat...
Cite
CITATION STYLE
APA
Bonaca, M. P., Scirica, B. M., Creager, M. A., Olin, J., Bounameaux, H., Dellborg, M., … Morrow, D. A. (2013). Vorapaxar in Patients With Peripheral Artery Disease. Circulation, 127(14), 1522–1529. https://doi.org/10.1161/circulationaha.112.000679
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free